10-60345018-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.114+44407A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.502 in 151,974 control chromosomes in the GnomAD database, including 19,714 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 19714 hom., cov: 32)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.82

Publications

5 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.669 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.114+44407A>G intron_variant Intron 1 of 43 ENST00000280772.7 NP_066267.2 Q12955-3
ANK3NM_001204404.2 linkc.64-65379A>G intron_variant Intron 1 of 43 NP_001191333.1 Q12955-4
ANK3NM_001320874.2 linkc.114+44407A>G intron_variant Intron 1 of 42 NP_001307803.1
ANK3NM_001204403.2 linkc.97-65379A>G intron_variant Intron 2 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.114+44407A>G intron_variant Intron 1 of 43 1 NM_020987.5 ENSP00000280772.1 Q12955-3

Frequencies

GnomAD3 genomes
AF:
0.502
AC:
76248
AN:
151856
Hom.:
19700
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.395
Gnomad AMI
AF:
0.361
Gnomad AMR
AF:
0.552
Gnomad ASJ
AF:
0.521
Gnomad EAS
AF:
0.689
Gnomad SAS
AF:
0.606
Gnomad FIN
AF:
0.605
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.519
Gnomad OTH
AF:
0.505
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.502
AC:
76302
AN:
151974
Hom.:
19714
Cov.:
32
AF XY:
0.512
AC XY:
38021
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.395
AC:
16395
AN:
41460
American (AMR)
AF:
0.553
AC:
8437
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.521
AC:
1807
AN:
3470
East Asian (EAS)
AF:
0.688
AC:
3545
AN:
5154
South Asian (SAS)
AF:
0.604
AC:
2914
AN:
4822
European-Finnish (FIN)
AF:
0.605
AC:
6382
AN:
10542
Middle Eastern (MID)
AF:
0.592
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
0.519
AC:
35249
AN:
67946
Other (OTH)
AF:
0.507
AC:
1070
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1913
3826
5738
7651
9564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.505
Hom.:
58450
Bravo
AF:
0.490
Asia WGS
AF:
0.625
AC:
2172
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.060
DANN
Benign
0.44
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4582919; hg19: chr10-62104776; API